Sign In
Buy CMPGY
$32.39
+0.120 (+0.372%)
At Close: Jun 03, 2026
Compass Pathways Announces FDA Granted NDA Rolling Review Request and Awarded Commissioner's National Priority Voucher
10:37am, Friday, 24'th Apr 2026
LONDON & NEW YORK--(BUSINESS WIRE)---- $CMPS #Biotech--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental heal
Compass Minerals: Pittsburgh's Ice Reveals The Value Chain
09:42pm, Tuesday, 21'st Apr 2026
Compass Minerals holds structural advantages in salt production, with irreplaceable assets and geographic reach supporting a premium market position. Loss of the SHACOG contract impacts only about 1%
Compass Diversified Announces First Quarter 2026 Earnings and Conference Call Information
04:10pm, Tuesday, 21'st Apr 2026
WESTPORT, Conn., April 21, 2026 (GLOBE NEWSWIRE) -- Compass Diversified (NYSE: CODI) (“CODI” or the “Company”), an owner of leading middle-market branded consumer and industrial businesses, an
Compass Pathways: Red Hot Psychedelic Market For Pioneer With Near Term Psychedelic Filing In TRD
11:45am, Tuesday, 21'st Apr 2026
Compass Pathways plc (CMPS) has faced significant risks since my last 'Buy' rating in January 2026. CMPS shares had declined approximately 10% over the intervening months, but then registered huge gai
Compass, Inc. to Announce First Quarter Results on May 5
07:00am, Tuesday, 21'st Apr 2026
NEW YORK, April 21, 2026 /PRNewswire/ -- Compass, Inc., d/b/a Compass International Holdings (the "Company") (NYSE: COMP), a global real estate services company, announced its first quarter 2026 finan
Compass Pathways Collaborates with Osmind to Advance Independent Clinic Readiness for Psychedelic Treatments
06:30am, Tuesday, 21'st Apr 2026
LONDON & NEW YORK--(BUSINESS WIRE)---- $CMPS #Biotech--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation announced toda
Why Compass Pathways Stock Rocketed 40% Today
12:02pm, Monday, 20'th Apr 2026
Compass Pathways has already reported two positive phase 3 trials for treatment-resistant depression (TRD). The company's COMP360 synthetic psilocybin treatment could now be on a faster track for appr
Compass Pathways: The Bull Case Is Early, Not Wrong
11:26am, Monday, 20'th Apr 2026
COMPASS Pathways plc is developing pharmaceutical-grade psilocybin treatments for severe mental health conditions, notably treatment-resistant depression. CMPS remains a pipeline-stage biotech with no
Compass: Clarity Is Lacking, But I'm Bullish Anyway
10:49am, Monday, 20'th Apr 2026
Compass, Inc. remains a Buy following its transformative merger with Anywhere Real Estate, despite recent underperformance versus the S&P 500. COMP's pro forma EBITDA could reach $643.4M, or up to $86
Compass Pathways to Participate in Needham Virtual Psychedelics Forum on April 27, 2026
06:30am, Monday, 20'th Apr 2026
LONDON & NEW YORK--(BUSINESS WIRE)---- $CMPS #Biotech--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental heal
Compass Pathways Commends White House Executive Order to Accelerate Research and Access for Psychedelic Treatments
04:12pm, Saturday, 18'th Apr 2026
LONDON & NEW YORK--(BUSINESS WIRE)---- $CMPS #Biotech--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation, welcomes the
SRx Health Solutions Acquires Shares of Compass Inc. and Increases Investment in Opendoor Technologies Inc.
08:30am, Thursday, 16'th Apr 2026
SRXH files Form S-4 with SEC in connection with EMJX merger SRXH provides update on performance through mid-April with an approximate 3.5% gain in hedging pool, driven by EMJX's algorithm, and an ap
Compass Minerals Sets Date for Conference Call to Discuss Second-Quarter Fiscal 2026 Results
04:35pm, Wednesday, 15'th Apr 2026
OVERLAND PARK, Kan.--(BUSINESS WIRE)--Compass Minerals (NYSE: CMP), a leading global provider of essential minerals, will release its second-quarter fiscal 2026 results on Wednesday, May 6, 2026, afte
Rocket's AI Push and Compass Deal Could Shift Mortgage Share
11:25am, Wednesday, 15'th Apr 2026
RKT bets on AI, servicing scale and a Compass deal to drive mortgage share gains, but execution risks and housing headwinds cloud timing.
Compass Pathways Announces U.S Grant Program for the Creation of Post-Approval COMP360 Provider Training
06:30am, Tuesday, 14'th Apr 2026
LONDON & NEW YORK--(BUSINESS WIRE)---- $CMPS #Biotech--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental heal
